Literature DB >> 32308067

Trend from 2001 to 2015 in the prevalence of bronchiectasis among patients hospitalized for asthma and effect of bronchiectasis on the in-hospital mortality.

Gema Sánchez-Muñoz1, Ana López-de-Andrés2, Rodrigo Jiménez-García3, Valentín Hernández-Barrera2, Fernando Pedraza-Serrano1, Luis Puente-Maestu1, Javier de Miguel-Díez1.   

Abstract

OBJECTIVE: We aimed to analyze the prevalence of bronchiectasis among patients hospitalized with asthma and to assess the effect of suffering bronchiectasis on in-hospital mortality (IHM).
METHODS: We used the Spanish National Hospital Discharge Database from 2000 to 2015 to evaluate all admissions for asthma exacerbation as the main diagnosis, dividing them according to the presence or absence of associated bronchiectasis. We assessed time trends in the prevalence, clinical characteristics, length of hospital stay, costs, and IHM.
RESULTS: Of 342,644 admissions for asthma, 10,377 (3.02%) had bronchiectasis. The prevalence of bronchiectasis increased from 2.16% in 2001 to 4.47% in 2015 (p < 0.001). Compared to patients without bronchiectasis, those with bronchiectasis were more frequently women (77.06% vs. 22.94%, p < 0.001), were older (68.87 ± 15.16 vs. 47.05 ± 30.66 years, p < 0.001) and had more comorbid conditions (Charlson comorbidity index ≥ 2: 9.45% vs. 6.58%, p < 0.001). Pseudomonas (8% vs. 0.66%, p < 0.001), Aspergillus (0.93% vs. 0.15%, p < 0.001), eosinophilia (0.29% vs. 0.17%, p = 0.005) and IHM (2.07% vs. 1.2%, p < 0.001) were more frequent in patients with bronchiectasis. After multivariable adjustments, IHM was not associated with bronchiectasis. The presence of bronchiectasis was associated with a longer length of hospital stay and higher costs.
CONCLUSIONS: Admissions for asthma with bronchiectasis have increased over time in Spain. In our investigation, the presence of bronchiectasis was not associated with higher IHM, but it increased the length of hospital stay and costs.

Entities:  

Keywords:  Bronchial asthma; bronchiectasis; cost; in-hospital mortality; prevalence; readmission

Year:  2020        PMID: 32308067     DOI: 10.1080/02770903.2020.1759086

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  3 in total

1.  Additive effects of coexisting respiratory comorbidities on overall or respiratory mortality in patients with asthma: a national cohort study.

Authors:  Yoomi Yeo; Hyun Lee; Jiin Ryu; Kyung Hoon Min; Ji-Yong Moon; Sung Jun Chung; Tai Sun Park; Dong Won Park; Sang-Heon Kim; Tae Hyung Kim; Jang Won Sohn; Ho Joo Yoon
Journal:  Sci Rep       Date:  2022-05-16       Impact factor: 4.996

Review 2.  Impact of Pseudomonas aeruginosa Infection on Patients with Chronic Inflammatory Airway Diseases.

Authors:  Marta Garcia-Clemente; David de la Rosa; Luis Máiz; Rosa Girón; Marina Blanco; Casilda Olveira; Rafael Canton; Miguel Angel Martinez-García
Journal:  J Clin Med       Date:  2020-11-24       Impact factor: 4.241

3.  Increasing prevalence and burden of bronchiectasis in urban Chinese adults, 2013-2017: a nationwide population-based cohort study.

Authors:  Jingnan Feng; Lina Sun; Siyan Zhan; Yahong Chen; Shengfeng Wang; Yongchang Sun; Xiaoyan Sun; Lu Xu; Lili Liu; Guozhen Liu; Jinxi Wang; Pei Gao
Journal:  Respir Res       Date:  2022-05-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.